Basic Information
ID: ALA3767927
Type: Functional
Description: Potentiation of temozolomide-induced cytotoxicity in human LoVo cells assessed as temozolomide GI50 at 0.4 uM after 5 days by Celltiter-Glo assay
Organism: Homo sapiens
Cell type: LoVo
Activity Charts
Bioactivity
Activity Types for Assay ALA3767927
GI50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 434.47 | 2.35 | 2.35 |
| 244.30 | 1.26 | 1.26 |
| 320.40 | 2.59 | 2.59 |
| 323.37 | 2.98 | 2.98 |
| 380.36 | 2.63 | 2.63 |
| 362.37 | 2.49 | 2.49 |
| 426.50 | 4.57 | 4.57 |
| 426.50 | 4.57 | 4.57 |
| 380.36 | 2.63 | 2.63 |
| 339.40 | 4.22 | 4.22 |
| 396.49 | 4.28 | 4.28 |
| 396.49 | 4.28 | 4.28 |
| 396.49 | 4.28 | 4.28 |
| 396.49 | 4.28 | 4.28 |
| 453.59 | 4.35 | 4.35 |
| 438.58 | 5.41 | 5.41 |
| 410.52 | 4.59 | 4.59 |
| 464.49 | 5.30 | 5.30 |
| 414.48 | 4.42 | 4.42 |
| 414.48 | 4.42 | 4.42 |
| 432.47 | 4.56 | 4.56 |
| 451.57 | 3.97 | 3.97 |
| 422.53 | 4.82 | 4.82 |
| 408.51 | 4.43 | 4.43 |
| 440.52 | 4.96 | 4.96 |
| 426.50 | 4.57 | 4.57 |
| 341.37 | 3.01 | 3.01 |
| 343.39 | 2.96 | 2.96 |
| 343.39 | 2.96 | 2.96 |
| 361.38 | 3.09 | 3.09 |
| 361.38 | 3.09 | 3.09 |
| 364.40 | 3.82 | 3.82 |
| 379.37 | 3.23 | 3.23 |
| 411.39 | 3.97 | 3.97 |
| 377.83 | 3.61 | 3.61 |
| 379.37 | 3.23 | 3.23 |
| 344.38 | 2.35 | 2.35 |
| 362.37 | 2.49 | 2.49 |
| 344.38 | 2.35 | 2.35 |
| 362.37 | 2.49 | 2.49 |
| 380.36 | 2.63 | 2.63 |
| 361.38 | 3.09 | 3.09 |
| 361.38 | 3.09 | 3.09 |
| 379.37 | 3.23 | 3.23 |
| 379.37 | 3.23 | 3.23 |
| 362.37 | 2.49 | 2.49 |